Skip to content

Clinical trials

Phase 3 Autistic Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Phase: Phase 3 Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20042
20052
20063
20075
20081
20091
20104
20111
20124
20132
20152
20161
20182
20192
20201
20211
20221
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Terminated5
Recruiting2
Active, not recruiting1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Curemark4
Indiana University4
The University of Hong Kong4
Massachusetts General Hospital3
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
Neuropharm2
Otsuka Pharmaceutical Co., Ltd.2
Repligen Corporation2
Sumitomo Pharma America, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder48
Autism Spectrum Disorder16
Child Development Disorders, Pervasive4
Asperger Syndrome3
Marijuana Abuse2
Schizophrenia2
Attention Deficit Disorder with Hyperactivity1
Bipolar Disorder1
Developmental Disabilities1
Rett Syndrome1

Trials

Showing 76 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.